Codiak BioSciences, Inc. (CDAK) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17
	10-K	10-K	10-K	S-1	S-1
Revenues	22.9	2.9	0.4	0.0	21.3
Revenue growth	686.8%	651.3%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	42.6
Gross profit	22.9	2.9	0.4	0.0	-21.3
Gross margin	100.0%	100.0%	100.0%		-100.0%
Selling, general and administrative [+]	27.6	19.9	21.0	9.9	6.2
General and administrative	27.6	19.9	21.0	9.9	6.2
Research and development	64.9	74.0	59.5	28.5
Other operating expenses	-33.3
EBITDA [+]	-30.9	-86.6	-77.4	-36.6	-26.1
EBITDA growth	-64.3%	11.9%	111.2%	40.2%
EBITDA margin	-134.8%	-2969.3%	-19943.3%		-122.6%
Depreciation and amortization	5.3	4.4	2.8	1.7	1.4
EBIT [+]	-36.3	-90.9	-80.2	-38.4	-27.5
EBIT growth	-60.1%	13.4%	108.9%	39.5%
EBIT margin	-158.1%	-3119.0%	-20657.7%		-129.0%
Non-recurring items [+]	33.3			8.1
Loss (gain) on disposal of assets	33.3
In-process research & development				8.1
Interest expense, net [+]	2.7	1.7	-1.2	-1.4	-0.5
Interest expense	2.7	1.9	0.3
Interest income	0.0	0.3	1.5	1.4	0.5
Other income (expense), net [+]	35.1	0.9	1.0	0.5
Other non-operating income	1.8	0.9	1.0	0.5
Other	1.8	0.9	-1.0	0.5
Pre-tax income	-37.2	-91.7	-78.0	-44.5	-27.0
Income taxes	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-37.2	-102.5	-91.7	-58.2	0.0
Net margin	-162.0%	-3516.2%	-23624.0%		-0.2%

Basic EPS [+]	($1.70)	($16.18)	($30.66)	($23.07)	($1.88)
Growth	-89.5%	-47.2%	32.9%	1127.9%
Diluted EPS [+]	($1.70)	($16.18)	($30.66)	($23.07)	($1.88)
Growth	-89.5%	-47.2%	32.9%	1127.9%

Shares outstanding (basic) [+]	21.8	6.3	3.0	2.5	0.0
Growth	244.2%	111.8%	18.4%	13297.0%
Shares outstanding (diluted) [+]	21.8	6.3	3.0	2.5	0.0
Growth	244.2%	111.8%	18.4%	13297.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.